Insider · CIK 0001864486

Yazji Salim

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001864486

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-02-14	Oncternal Therapeutics, Inc.Stock OptionA Award	Chief Medical Officer	AAward	+14.2K sh	—	—	14,200
2024-01-03	Oncternal Therapeutics, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−19.7K sh	$0.50	−$9,794.006	128,635
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−354K sh	—	—	0
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−92.1K sh	—	—	0
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−55K sh	—	—	0
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−210K sh	—	—	0
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionA Award	Chief Medical Officer	AAward	+354K sh	—	—	354,400
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionA Award	Chief Medical Officer	AAward	+92.1K sh	—	—	92,075
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionA Award	Chief Medical Officer	AAward	+55K sh	—	—	55,000
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionA Award	Chief Medical Officer	AAward	+210K sh	—	—	210,000
2023-10-02	Oncternal Therapeutics, Inc.Stock OptionA Award	Chief Medical Officer	AAward	+70.6K sh	—	—	70,600
2023-07-03	Oncternal Therapeutics, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−16.3K sh	$0.36	−$5,867.64	148,377
2023-04-14	Oncternal Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+5,000 sh	$0.30	+$1,500	164,676
2023-04-13	Oncternal Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+10K sh	$0.28	+$2,850	159,676
2023-04-12	Oncternal Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+10K sh	$0.28	+$2,850	149,676
2023-02-21	Oncternal Therapeutics, Inc.Stock OptionA Award	Chief Medical Officer	AAward	+210K sh	—	—	210,000
2023-01-03	Oncternal Therapeutics, Inc.F Tax Payment	Chief Medical Officer	FTax Payment	−9,961 sh	$1.02	−$10.2K	139,676
2022-07-28	Oncternal Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+82.5K sh	—	—	149,637
2022-07-28	Oncternal Therapeutics, Inc.Stock OptionA Award	Chief Medical Officer	AAward	+55K sh	—	—	55,000
2022-01-27	Oncternal Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+10K sh	$1.69	+$16.9K	67,137
2022-01-20	Oncternal Therapeutics, Inc.Stock OptionA Award	Chief Medical Officer	AAward	+92.1K sh	—	—	92,075
2022-01-03	Oncternal Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+57.1K sh	—	—	57,137

Recent filings

Accepted (ET)
Feb 154
Yazji Salim0001209191-24-003409
SEC(opens sec.gov)
Jan 54
Yazji Salim0001209191-24-000973
SEC(opens sec.gov)
Oct 44
Yazji Salim0001209191-23-052022
SEC(opens sec.gov)
Jul 54
Yazji Salim0001209191-23-041314
SEC(opens sec.gov)
Apr 144
Yazji Salim0001209191-23-024371
SEC(opens sec.gov)
Feb 234
Yazji Salim0001209191-23-012402
SEC(opens sec.gov)
Jan 54
Yazji Salim0001209191-23-002029
SEC(opens sec.gov)
Aug 14
Yazji Salim0001209191-22-043734
SEC(opens sec.gov)
Jan 314
Yazji Salim0001209191-22-005557
SEC(opens sec.gov)

Companies

Oncternal Therapeutics, Inc.Chief Medical Officer

Address

12230 EL CAMINO REAL, SUITE 300

SAN DIEGO, CA, 92130